The Japanese Journal of Urology
Online ISSN : 1884-7110
Print ISSN : 0021-5287
ISSN-L : 0021-5287
Volume 117, Issue 1
Displaying 1-5 of 5 articles from this issue
Original Articles
  • Yuma Sakura, Ryo Yamashita, Kana Ito, Hideo Shinsaka, Masafumi Nakamur ...
    2026Volume 117Issue 1 Pages 1-8
    Published: January 20, 2026
    Released on J-STAGE: October 09, 2026
    JOURNAL FREE ACCESS

    (Objective) This retrospective study investigates the correlation between relative dose intensity (RDI) and the clinical efficacy of enfortumab vedotin (EV) in clinical practice.

    (Subjects and methods) We analyzed 40 patients who received at least two cycles of EV monotherapy for unresectable or metastatic urothelial carcinoma at our hospital between January 2022 and April 2024. RDI was calculated for the total treatment period (Total-RDI) and the first two and four cycles (2-cycle RDI/4-cycle RDI). Patients were then categorized into two groups based on the median RDI; differences in patient characteristics, overall response rate, progression-free survival (PFS), and overall survival (OS) were then evaluated.

    (Results) The median observation period from the start of EV treatment was 14.1 months, and the median number of treatment cycles was 8.5. The response rate was 55%, with four cases of complete response (CR) and 18 cases of partial response (PR). The median RDI decreased during the first four cycles and then stabilized at approximately 0.6. The median Total-RDI was 0.57. PFS and OS were significantly longer in patients with Total-RDI <0.57 than in those with Total-RDI ≥0.57 (PFS: 16.4 months vs. 6.0 months, p=0.007; OS: not reached vs. 15.1 months, p=0.004). Among patients who responded to EV treatment (n=22), the Total-RDI was 0.49 in the CR group and 0.52 in the PR group, whereas the 2-cycle RDI/ the 4-cycle RDI were 0.62/0.73 in the CR group and 0.71/0.59 in the PR group.

    (Conclusion) The median RDI of EV treatment decreased over the first four cycles and then stabilized. Of note, a reduction in RDI during the treatment period did not negatively impact treatment efficacy.

    Download PDF (386K)
  • Tatsuro Sanami, Masayuki Tasaki, Shoko Ishikawa, Masahiro Ikeda, Tsuto ...
    2026Volume 117Issue 1 Pages 9-15
    Published: January 20, 2026
    Released on J-STAGE: October 09, 2026
    JOURNAL FREE ACCESS

    (Objective) Since the revision of the Organ Transplant Law in our country in 2010, the primary source of deceased organ donation has shifted from donation after cardiac death (DCD) to donation after brain death (DBD). Although the graft survival rate of living donor (LD) kidney transplantation has generally surpassed that of deceased donor kidney transplantation, few studies have directly compared outcomes between DCD and DBD.

    (Subjects and methods) We conducted a retrospective analysis of 213 patients who underwent kidney transplantation at our institution between 2011 and 2023. ABO-incompatible transplants and those with pre-existing anti-donor HLA antibodies were excluded. Patients were categorized into three groups according to donor status: DCD (n = 25), DBD (n = 39), and LD (n = 149).

    (Results) The median recipient ages were 56 years (DCD), 52 years (DBD), and 41 years (LD), while the median donor ages were 47 years (DCD), 45 years (DBD), and 61 years (LD). The proportion of HLA-DR 0 mismatch was 36% in DCD, 59% in DBD, and 24.8% in LD. Graft survival rates at 10 years were 83.2% for DCD; 100% for DBD; and 88.3% for LD, respectively.

    Multivariate analysis identified biopsy proven rejection as the only independent predictor of graft survival.

    (Conclusion) Despite the disadvantages of longer ischemic times and dialysis durations prior to transplantation, DBD grafts demonstrated the highest graft survival rates. These favorable outcomes may be attributed to a lower frequency of HLA-DR mismatches and reduced incidence of rejection.

    Download PDF (713K)
Case Reports
  • Mayuko Yamaguchi, Hiroki Ide, Sotaro Kitaoka, Chugo Nishimura, Akari K ...
    2026Volume 117Issue 1 Pages 16-19
    Published: January 20, 2026
    Released on J-STAGE: October 09, 2026
    JOURNAL FREE ACCESS

    A 56-year-old male patient underwent transurethral resection of a bladder tumor (TURBT), the pathological diagnosis of which was urothelial carcinoma with sarcomatoid subtype, stage T1. Despite the absence of lesions in the upper urinary tract, multiple slightly enlarged para-aortic lymph nodes measuring less than 1 cm were detected on computed tomography. One year after TURBT, the patient exhibited recurrent thromboembolic events despite receiving anticoagulant therapy. As the para-aortic lymph nodes continued to enlarge, an open lymph node biopsy was performed, which revealed urothelial carcinoma. These findings suggest that the occurrence of thromboembolic events can be attributed to Trousseau's syndrome in conjunction with metastatic bladder cancer.

    Download PDF (740K)
  • Yurina Fujimori, Akihiro Kanematsu, Takahiro Hayashi, Koji Shigesaka, ...
    2026Volume 117Issue 1 Pages 20-25
    Published: January 20, 2026
    Released on J-STAGE: October 09, 2026
    JOURNAL FREE ACCESS

    We report our initial experiences with transvaginal bladder neck closure for two females with a devastated bladder neck. In each, the bladder neck was closed following a circumferential dissection and the suture line covered using an anterior vaginal flap, with urine draining via a suprapubic cystostomy tube.

    (Case 1) A female in her twenties was presented with urinary incontinence. The patient had been paraplegic since childhood and initially managed with intermittent catheterization. Later, severe incontinence developed, and Foley catheter was placed. At presentation, the urethra and bladder neck were widely lacerated. Primary closure of the bladder neck and fascial sling placement were performed but she remained incontinent. Transvaginal bladder neck closure was thus performed, and she became continent.

    (Case 2) A female in her forties came to us with urinary incontinence. This patient had also been paraplegic since childhood and was initially maintained on intermittent catheterization as initial management, after which a Foley catheter was placed. A bladder neck laceration was noted before surgical repair, thus transvaginal bladder neck closure with simultaneous suprapubic cystostomy tube placement was performed.

    (Conclusion) This is the initial report of patients in Japan who underwent transvaginal bladder neck closure. The procedure was effective in both cases and should be considered for incontinent women with an irreparable bladder outlet.

    Download PDF (1423K)
  • Kazuki Nakamura, Akihiro Maeda, Kazuma Udo, Maki Kawasaki, Hiroaki Kak ...
    2026Volume 117Issue 1 Pages 26-30
    Published: January 20, 2026
    Released on J-STAGE: October 09, 2026
    JOURNAL FREE ACCESS

    We herein report a rare case of malacoplakia of the urinary bladder that demonstrated significant diagnostic difficulty. The patient was a 65-year-old woman with a history of breast cancer, dermatomyositis, steroid-induced diabetes mellitus, and cutaneous cryptococcosis. She presented with repeated episodes of dysuria and hematuria since the age of 62. Computed tomography (CT) revealed progressive bladder wall thickening, and she was therefore diagnosed with cystitis by her primary care physician and treated with antibiotics. Her symptoms worsened at 63 years of age, and further bladder wall thickening was observed on follow-up CT, thus prompting referral to our department. Although cystoscopy revealed an erythematous and irregular mucosa, no distinct bladder tumor was observed. Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli was isolated from a urine culture, but it was considered to represent colonization, and only symptomatic treatment was provided.

    At 64 years of age, abdominal ultrasonography revealed multiple broad-based nonpapillary intravesical masses. Magnetic resonance imaging (MRI) revealed multiple tumors with a low signal intensity on T2-weighted images. The differential diagnoses included urothelial carcinoma, malignant lymphoma, and metastatic breast cancer. Transurethral resection of the bladder tumor (TURBT) was performed, and the largest lesion was resected for a pathological evaluation. The histopathological findings revealed the infiltration of inflammatory cells, including plasma cells, lymphocytes, and neutrophils, along with PAS- and Alcian blue-positive spherical bodies, thus suggesting disseminated cryptococcosis. However, cryptococcal antigen tests in the blood and urine were negative, and Grocott staining did not reveal any fungal elements. Ultimately, the presence of Michaelis-Gutmann bodies confirmed the diagnosis of malacoplakia of the urinary bladder.

    The patient's urinary symptoms improved after oral antibiotic therapy with levofloxacin. Although residual lesions were observed on follow-up cystoscopy, there were no obstructive or irritative symptoms and the patient thereafter remained under observation without any additional treatment.

    Download PDF (1968K)
feedback
Top